GeoPolitics Pulse

The Heartbeat of World events

DMD gene therapy Elevidys wins conditional approval in Japan

by ·

The approval allows the DMD gene therapy to be sold in Japan for up to seven years, but more trials will be needed for full approval.Read More

Related posts:

  1. Sarepta Therapeutics Announces Approval in Japan of ELEVIDYS, a Gene Therapy to Treat …
  2. European Commission grants conditional marketing authorization to Pfizer’s gene therapy …
  3. Pfizer’s hemophilia B gene therapy snags EU approval – Fierce Pharma
  4. Singapore cardio gene therapy biotech collects $45M as it plots Europe expansion
  5. SIA, ANA win conditional approval for JV – Asian Aviation